Ken Berlin
Directeur Général chez ADVAXIS, INC.
Fortune : 155 $ au 30/04/2024
Profil
Kenneth A.
Berlin is currently the President, Chief Executive Officer & Director at Old Ayala, Inc., Chief Executive Officer & Director at Biosight Therapeutics, Inc., President, Chief Executive Officer & Director at Ayala Pharmaceuticals, Inc., and President at Rosetta Genomics, Inc. He was previously the President & Chief Executive Officer at Rosetta Genomics Ltd., President, Chief Executive Officer, CFO & Director at Advaxis, Inc., Vice President-Franchise Development at Johnson & Johnson, General Manager-Worldwide at Newell Brands, Inc., General Manager at Veridex LLC, and Vice President-Worldwide Franchise Development at Ortho-Clinical Diagnostics, Inc. He received his undergraduate degree from Princeton University and his graduate degree from UCLA School of Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/12/2022 | 271 ( 0,00% ) | 149 $ | 30/04/2024 | |
| 12/12/2022 | 10 ( 0,00% ) | 6 $ | 30/04/2024 |
Postes actifs de Ken Berlin
| Sociétés | Poste | Début |
|---|---|---|
| ADVAXIS, INC. | Directeur Général | 19/01/2023 |
| AYALA PHARMACEUTICALS, INC. | Directeur Général | 01/04/2018 |
Rosetta Genomics, Inc.
 Rosetta Genomics, Inc. Medical/Nursing ServicesHealth Services Part of Rosetta Genomics Ltd., Rosetta Genomics, Inc. is a company that focuses on targeted therapies for cancer. The company is based in Philadelphia, PA. The company's website provides information about their blog on cancer research and healthy living tips for World Cancer Day. The blog aims to educate people about the challenges of cancer and the need for targeted therapies. The company also participated in World Cancer Day 2015 to raise awareness about the fight against cancer. | President | - |
Anciens postes connus de Ken Berlin
| Sociétés | Poste | Fin |
|---|---|---|
| ROSETTA GENOMICS LTD. | Directeur Général | 01/04/2018 |
Veridex LLC
 Veridex LLC Medical SpecialtiesHealth Technology Part of Kenvue, Inc., Veridex LLC is a company that supplies vitro diagnostic oncology products. The company is based in Raritan, NJ. | Corporate Officer/Principal | 01/01/2009 |
Ortho-Clinical Diagnostics, Inc.
 Ortho-Clinical Diagnostics, Inc. Medical SpecialtiesHealth Technology Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ. | Corporate Officer/Principal | 01/01/2007 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/01/2007 |
| AYALA PHARMACEUTICALS, INC. | Directeur Général | - |
Formation de Ken Berlin
| Princeton University | Undergraduate Degree |
| UCLA School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ROSETTA GENOMICS LTD. | Health Technology |
| NEWELL BRANDS INC. | Producer Manufacturing |
| JOHNSON & JOHNSON | Health Technology |
| AYALA PHARMACEUTICALS, INC. | Commercial Services |
| Entreprise privées | 5 |
|---|---|
Veridex LLC
Veridex LLC Medical SpecialtiesHealth Technology Part of Kenvue, Inc., Veridex LLC is a company that supplies vitro diagnostic oncology products. The company is based in Raritan, NJ. | Health Technology |
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
Ortho-Clinical Diagnostics, Inc.
Ortho-Clinical Diagnostics, Inc. Medical SpecialtiesHealth Technology Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ. | Health Technology |
Old Ayala, Inc.
 Old Ayala, Inc. Pharmaceuticals: MajorHealth Technology Old Ayala, Inc. operates as a clinical-stage oncology company. It focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. It also involved in in precision oncology, targeted therapy, drug development, companion diagnostics, and biomarkers. The company was founded in November 2017 and is headquartered in Rehovot, Israel. | Health Technology |
Rosetta Genomics, Inc.
Rosetta Genomics, Inc. Medical/Nursing ServicesHealth Services Part of Rosetta Genomics Ltd., Rosetta Genomics, Inc. is a company that focuses on targeted therapies for cancer. The company is based in Philadelphia, PA. The company's website provides information about their blog on cancer research and healthy living tips for World Cancer Day. The blog aims to educate people about the challenges of cancer and the need for targeted therapies. The company also participated in World Cancer Day 2015 to raise awareness about the fight against cancer. | Health Services |